Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness

Abstract

Background: People with severe mental disorders (SMD) experience premature mortality mostly from preventable physical causes. The World Health Organization (WHO) have recently produced guidelines on the management of physical health conditions in SMD. This paper presents the evidence which led to the recommendations for tobacco cessation and management of substance use disorders in SMD. Methods: Scoping reviews informed 2 PICO (Population Intervention, Comparator, Outcome) questions relating to tobacco cessation and management of substance use disorders in SMD. Systematic searches led to the identification of systematic reviews with relevant evidence to address these questions. Retrieved evidence was assessed using GRADE methodology, informing the development of guidelines. Results: One thousand four hundred thirty-four records were identified through systematic searches for SMD and tobacco cessation, of which 4 reviews were included in GRADE tables and 18 reviews in narrative synthesis. For SMD and substance use disorders, 4268 records were identified, of which 4 studies from reviews were included in GRADE tables and 16 studies in narrative synthesis. People with SMD who use tobacco should be offered combined pharmacological (Varenicline, Bupropion or Nicotine Replacement Therapy) and non-pharmacological interventions such as tailored directive and supportive behavioural interventions. For people with SMD and substance use disorders (drug and/or alcohol), interventions should be considered in accordance with WHO mhGAP guidelines. Prescribers should note potential drug-drug interactions. Recommendation were conditional and based on low/very low certainty of evidence with a scarcity of evidence from

A qualitative study on people with opioid use disorders’ perspectives on smoking and smoking cessation interventions

“…Although persons with SUDs are perceived as a “hard-to-reach” population regarding smoking cessation ( 15 , 16 , 26 , 49 , 50 ), our study indicates that patients receiving OAT have motivations, capabilities, and opportunities to make smoking cessation attempts. Among patients receiving buprenorphine, motivational interviewing and cognitive behavioral therapy increased motivation to make a cessation attempt ( 51 ).…”

“…An illustration of how the themes and codes were developed is shown in Figure 2. The Consolidated Criteria for Reporting Qualitative Research (COREQ) were used in writing this manuscript (48). The COREQ checklist is presented in Supplementary file 2.…”

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations

“…This evidence should urge WHO to try to keep this tool regularly updated. Over the last ten years the WHO has made a tremendous effort to produce, and regularly update, a number of evidence-based tools in the area of mental health, including recommendations [ 21 – 26 ], evidence-based intervention guides [ 27 ], and related implementation and operational manuals. These tools include up-to-date recommendations on selection and rational use of psychotropic medicines that not always fully match with the essential psychotropic medicines included in the WHO Model List of Essential Medicines.…”

Os desafios na adesão ao tratamento para cessar o tabagismo: uma revisão integrativa

“…Ocorre que o desejo de querer a cessação do hábito de fumar pelo paciente tabagista e a necessidade de se questionar sobre o hábito que possui são pontos que dependem exclusivamente do indivíduo e podem, sim, dificultar a adesão à cessação do tabagismo 11 . Entretanto, apoio social e tentativas de reduzir a exclusão social também são pontos que desempenham um importante papel nesse processo 14 .…”